A cost-analysis of conducting population-based prevalence surveys for the validation of the elimination of trachoma as a public health problem in Amhara, Ethiopia.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
09 2020
Historique:
received: 23 08 2019
accepted: 19 05 2020
revised: 16 09 2020
pubmed: 4 9 2020
medline: 28 10 2020
entrez: 4 9 2020
Statut: epublish

Résumé

Trachoma prevalence surveys, including impact surveys (TIS) and surveillance surveys (TSS), provide information to program managers on the impact of the SAFE (surgery, antibiotics, facial cleanliness, and environmental improvement) strategy and current burden of disease, and they provide a crucial component of the evidence base necessary for the validation of the elimination of trachoma as a public health problem. The prevalence surveys included in this analysis are multi-level cluster random surveys that provide population-based estimates for program planning. This study conducted an analysis of the cost of 8 rounds of TIS/TSS executed in Amhara, Ethiopia, 2012-2016, comprising 232,357 people examined over 1,828 clusters in 187 districts. Cost data were collected retrospectively from accounting and procurement records from the implementing partner, The Carter Center, and coded by survey activity (i.e. training and field work) and input category (i.e. personnel, transportation, supplies, venue rental, and other). Estimates of staff time were obtained from The Carter Center Ethiopia. Data were analyzed by activity and input category. The mean total cost per cluster surveyed was $752 (standard deviation $101). Primary cost drivers were personnel (39.6%) and transportation (49.2%), with costs increasing in the last 3 rounds of TIS/TSS. Despite the considerable cost of conducting TIS and TSS, these surveys provide necessary information for program managers. Limited options are available to reduce the costs of TIS/TSS and gain economies of scale, as the surveys must be designed to achieve their designated sample size. However, surveys must also be designed in a way that is possible to be executed given the financial resources, personnel, and time required. Program managers can use these findings to improve estimates of the total cost of a survey and its components to ensure that sufficient resources are budgeted accordingly.

Sections du résumé

BACKGROUND
Trachoma prevalence surveys, including impact surveys (TIS) and surveillance surveys (TSS), provide information to program managers on the impact of the SAFE (surgery, antibiotics, facial cleanliness, and environmental improvement) strategy and current burden of disease, and they provide a crucial component of the evidence base necessary for the validation of the elimination of trachoma as a public health problem. The prevalence surveys included in this analysis are multi-level cluster random surveys that provide population-based estimates for program planning. This study conducted an analysis of the cost of 8 rounds of TIS/TSS executed in Amhara, Ethiopia, 2012-2016, comprising 232,357 people examined over 1,828 clusters in 187 districts.
METHODOLOGY AND FINDINGS
Cost data were collected retrospectively from accounting and procurement records from the implementing partner, The Carter Center, and coded by survey activity (i.e. training and field work) and input category (i.e. personnel, transportation, supplies, venue rental, and other). Estimates of staff time were obtained from The Carter Center Ethiopia. Data were analyzed by activity and input category. The mean total cost per cluster surveyed was $752 (standard deviation $101). Primary cost drivers were personnel (39.6%) and transportation (49.2%), with costs increasing in the last 3 rounds of TIS/TSS.
CONCLUSION
Despite the considerable cost of conducting TIS and TSS, these surveys provide necessary information for program managers. Limited options are available to reduce the costs of TIS/TSS and gain economies of scale, as the surveys must be designed to achieve their designated sample size. However, surveys must also be designed in a way that is possible to be executed given the financial resources, personnel, and time required. Program managers can use these findings to improve estimates of the total cost of a survey and its components to ensure that sufficient resources are budgeted accordingly.

Identifiants

pubmed: 32881881
doi: 10.1371/journal.pntd.0008401
pii: PNTD-D-19-01223
pmc: PMC7494078
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008401

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2017 May 26;11(5):e0005599
pubmed: 28552961
Trans R Soc Trop Med Hyg. 2009 Oct;103(10):1001-10
pubmed: 19178920
Clin Infect Dis. 2018 Nov 28;67(12):1840-1846
pubmed: 29741592
Parasit Vectors. 2018 Jul 24;11(1):431
pubmed: 30041691
PLoS Negl Trop Dis. 2017 Feb 1;11(2):e0005097
pubmed: 28146557
PLoS One. 2013 Sep 16;8(9):e74570
pubmed: 24066147
Am J Trop Med Hyg. 2019 Dec;101(6):1286-1295
pubmed: 31549612
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
PLoS Negl Trop Dis. 2013 Jun 06;7(6):e2223
pubmed: 23755308
PLoS Negl Trop Dis. 2011 Mar 08;5(3):e979
pubmed: 21408130
PLoS Negl Trop Dis. 2017 Oct 18;11(10):e0006023
pubmed: 29045419
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
PLoS Negl Trop Dis. 2019 Sep 5;13(9):e0007605
pubmed: 31487281
Ophthalmic Epidemiol. 2005 Apr;12(2):91-101
pubmed: 16019692
PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2732
pubmed: 24625539
Bull World Health Organ. 1987;65(4):477-83
pubmed: 3500800
BMJ. 2012 Mar 02;344:e615
pubmed: 22389341

Auteurs

Randall P Slaven (RP)

The Carter Center, Atlanta, Georgia, United States of America.

Aisha E P Stewart (AEP)

The Carter Center, Atlanta, Georgia, United States of America.

Mulat Zerihun (M)

The Carter Center, Addis Ababa, Ethiopia.

Eshetu Sata (E)

The Carter Center, Addis Ababa, Ethiopia.

Tigist Astale (T)

The Carter Center, Addis Ababa, Ethiopia.

Berhanu Melak (B)

The Carter Center, Addis Ababa, Ethiopia.

Melsew Chanyalew (M)

Amhara Regional Health Bureau, Bahir Dar, Amhara, Ethiopia.

Demelash Gessese (D)

The Carter Center, Addis Ababa, Ethiopia.

Paul M Emerson (PM)

International Trachoma Initiative, Decatur, Georgia, United States of America.

Zerihun Tadesse (Z)

The Carter Center, Addis Ababa, Ethiopia.

E Kelly Callahan (EK)

The Carter Center, Atlanta, Georgia, United States of America.

Scott D Nash (SD)

The Carter Center, Atlanta, Georgia, United States of America.

Deborah A McFarland (DA)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH